The Life Lab by Death Clock Dr. Matthew Johnson on Therapeutic Psychedelics
14 snips
Sep 5, 2025 
Dr. Matthew Johnson, a psychiatry professor and leading psychedelic researcher, discusses therapeutic use of psilocybin, MDMA, and ketamine. He covers screening and safety, session setup and prep, dosing and intensity, integration practices, group therapy potential, and realistic expectations for these treatments.
AI Snips
Chapters
Books
Transcript
Episode notes
Expect High Intensity With Therapeutic Psilocybin Doses
- Use high, clinically controlled doses for therapeutic psilocybin sessions and expect intense psychological effects.
- Johnson describes 30–40 mg pure psilocybin (~5 dried grams) producing a 6-hour, often very challenging 'heroic' experience.
Design A Comfortable Room With Music And Eyeshades
- Create a comfortable, home-like treatment environment with music and non-intrusive aesthetics.
- Johnson advises music via speakers and headphones, eye shades, one-to-two session guides, and cozy decor to avoid a lab-like feel.
Use Eyeshades For Psilocybin And Talk For MDMA
- Encourage inward, eyes-closed experience for psilocybin and more talk for MDMA.
- Johnson says psilocybin sessions are ~80–90% eyeshade time; MDMA is ~50/50 because patients often want to talk about trauma.
